The nuclei of brain stem cells in some Parkinson's patients become misshapen with age. The discovery opens up new ways to target the disease.
Susan YoungFollow @twitterapi
I’m the biomedicine editor for MIT Technology Review. I look for stories where technology stands to improve human health or advance our understanding of the human condition.
I joined MIT Technology Review in March 2012 after a brief stint in the Washington, D.C., news bureau of the scientific journal Nature. Before I ventured to the East Coast, I spent several years in the San Francisco Bay Area as a doctoral student in molecular biology and one whirlwind year in science-writing boot camp in Santa Cruz.
In California, I wrote for the Stanford University press offices, the Multiple Sclerosis Discovery Forum, and the Salinas Californian newspaper. I grew up in a small town in eastern Texas, surrounded by bird song, rolling cattle fields, and lanky pine trees. When I’m not exploring health tech, you will probably find me cooking or giggling over an exceptional LOLcat.
Susan Young's Stories
Electrical stimulation of the visual cortex may one day give image perception to blind people.
Medtronic's device can sense changes in brain activity related to disease.
A company has developed a simple blood test to identify most cases of autism—but determining if it really works is not so simple.
Researchers think drivers could use their sensor-laden Mini Cooper as an aid to health.
Desperate to find new drugs, some pharmaceutical firms are outsourcing nearly half of their R&D budgets.
A $125,000 hardware-and-software system could help researchers analyze data securely and with less IT support.
The technology could enable therapeutic and diagnostic devices that are absorbed by the body after they are no longer needed.
Software that enables collaboration between labs could make it easier for doctors to translate genome information.
Therapeutics for one could work in the other, suggests the latest Cancer Genome Atlas study.